Clinical Trials Browser

Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaccinia

Low Grade Serous Ovarian Cancer

Ovarian Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Uterine Cervical Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Ovarian Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Neoplasms, Endometrial Neoplasms

Endometrial Neoplasms

Ovarian Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Neoplasm Metastasis, Uterine Neoplasms, Endometrial Neoplasms

Recurrence, Endometrial Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Uterine Cervical Neoplasms

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Neoplasms, Endometrial Neoplasms

Endometrial Neoplasms

Endometrial Neoplasms

Ovarian Neoplasms

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms

Breast Neoplasms, Neoplasms, Ovarian Neoplasms

Endometrial Neoplasms

Carcinoma, Ovarian Epithelial

Endometrial Neoplasms

Endometrial Neoplasms

Ovarian Neoplasms

Endometrial Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Pathologic Complete Response, Ovarian Neoplasms

Advanced Endometrial Cancer

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Ovarian Neoplasms

Uterine Cervical Neoplasms

Advanced Cervical Cancer

Uterine Cervical Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Uterine Cervical Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Clinical Trials

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

RAMP 301

Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer

MAESTRA 2

Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected

TroFuse-020

TroFuse-022

TroFuse-033

TroFuse-036

TroFuse-021

DE-01

A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-Endometrial01)

A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

KEYNOTE-B96

DO-01

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

RAINFOL-03

RAINFOL-04

MONO-OLA1

OVATION-3

innovaTV 301

GLORIOSA

KEYNOTE-A18

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

KEYNOTE-826

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

LEAP-001

Fern-EC-01

FLAMES

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

ROSY-O

DUoENDE

TREVI-OC-01

ASCENT-GYN-01

TroFuse-005

FIRST

DUO-E

HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer

A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

SOLO-1

Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer

Avelumab Program Rollover Study

A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

KEYLYNK-001

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer

Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer

ARTISTRY-7